You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR SELETRACETAM


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for Seletracetam

Trial ID Title Status Sponsor Phase Summary
NCT00152451 ↗ Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures Completed UCB Pharma Phase 2 This trial will evaluate the efficacy and safety of ucb 44212 as add on therapy in subjects with focal epilepsy.
NCT00152503 ↗ Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam Completed UCB Pharma Phase 2 This trial will evaluate the efficacy and safety of ucb 44212 as add-on therapy in subjects with focal epilepsy.
NCT00175851 ↗ Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy Withdrawn UCB Pharma Phase 3 This is a safety and efficacy study of add-on therapy with seletracetam in epilepsy patients who have participated in a previous seletracetam study
NCT00175864 ↗ Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy. Withdrawn UCB Pharma Phase 3 This is a safety and efficacy study of add on therapy with seletracetam in patients experiencing refractory epilepsy.
NCT00422110 ↗ A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures Withdrawn UCB Pharma Phase 2/Phase 3 This study will evaluate the effectiveness and safety of seletracetam when it is used in addition to other anti-epileptic medications by patients with partial onset seizures. It will also help to determine the best dose to use.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Seletracetam

Condition Name

Condition Name for
Intervention Trials
Epilepsy 2
Epilepsy, Partial 2
Epilepsies, Partial 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for
Intervention Trials
Epilepsy 5
Epilepsies, Partial 3
Seizures 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Seletracetam

Trials by Country

Trials by Country for
Location Trials
United States 20
Canada 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for
Location Trials
Virginia 2
Tennessee 2
Pennsylvania 2
Ohio 2
Arkansas 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Seletracetam

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 3 2
Phase 2/Phase 3 1
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Withdrawn 3
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Seletracetam

Sponsor Name

Sponsor Name for
Sponsor Trials
UCB Pharma 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.